Omicron variant: Current insights and future directions DOI Creative Commons

Rashmi Rana,

Ravi Kant,

Rohit Singh Huirem

и другие.

Microbiological Research, Год журнала: 2022, Номер 265, С. 127204 - 127204

Опубликована: Сен. 17, 2022

Язык: Английский

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic DOI Open Access
Markus Hoffmann, Nadine Krüger, Sebastian Schulz

и другие.

Cell, Год журнала: 2021, Номер 185(3), С. 447 - 456.e11

Опубликована: Дек. 24, 2021

Язык: Английский

Процитировано

881

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo DOI Open Access
Kenrie P. Y. Hui,

John Chi Wang Ho,

Man Chun Cheung

и другие.

Nature, Год журнала: 2022, Номер 603(7902), С. 715 - 720

Опубликована: Фев. 1, 2022

Язык: Английский

Процитировано

775

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway DOI Creative Commons
Brian J. Willett, Joe Grove, Oscar A. MacLean

и другие.

Nature Microbiology, Год журнала: 2022, Номер 7(8), С. 1161 - 1179

Опубликована: Июль 7, 2022

Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone public health response to COVID-19. The emergence hypermutated, increasingly transmissible variants concern (VOCs) threaten this strategy. Omicron (B.1.1.529), fifth VOC be described, harbours multiple amino acid mutations in spike, half which lie within receptor-binding domain. Here we demonstrate substantial evasion neutralization by BA.1 and BA.2 vitro using sera from individuals vaccinated with ChAdOx1, BNT162b2 mRNA-1273. These data were mirrored reduction real-world vaccine effectiveness that was partially restored booster vaccination. did not induce cell syncytia favoured TMPRSS2-independent endosomal entry pathway, these phenotypes mapping distinct regions protein. Impaired fusion determined domain, while mapped S2 Such marked changes antigenicity replicative biology may underlie rapid global spread altered pathogenicity variant.

Язык: Английский

Процитировано

557

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron DOI Open Access
Juan Manuel Carreño, Hala Alshammary, Johnstone Tcheou

и другие.

Nature, Год журнала: 2021, Номер 602(7898), С. 682 - 688

Опубликована: Дек. 31, 2021

Язык: Английский

Процитировано

477

The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant DOI
Dandan Tian, Yanhong Sun,

Huihong Xu

и другие.

Journal of Medical Virology, Год журнала: 2022, Номер 94(6), С. 2376 - 2383

Опубликована: Фев. 4, 2022

Recently, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (B.1.1.529) was first identified in Botswana November 2021. It reported to World Health Organization (WHO) on 24. On 26, 2021, according advice of scientists who are part WHO's Technical Advisory Group SARS-CoV-2 Virus Evolution (TAG-VE), WHO defined strain as a concern (VOC) and named it Omicron. Compared other four VOCs (Alpha, Beta, Gamma, Delta), most highly mutated strain, with 50 mutations accumulated throughout genome. The contains at least 32 spike protein, which twice many Delta variant. Studies have shown that carrying can increase infectivity immune escape compared early wild-type VOCs. is becoming dominant countries worldwide brings new challenges preventing controlling disease 2019 (COVID-19). current review article aims analyze summarize information data about biological characteristics amino acid mutations, epidemic characteristics, escape, vaccine reactivity variant, hoping provide scientific reference for monitoring, prevention, development strategies

Язык: Английский

Процитировано

442

Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic DOI Open Access
Rekha Khandia, Shailja Singhal, Taha Alqahtani

и другие.

Environmental Research, Год журнала: 2022, Номер 209, С. 112816 - 112816

Опубликована: Янв. 29, 2022

Язык: Английский

Процитировано

283

Structural biology of SARS-CoV-2: open the door for novel therapies DOI Creative Commons

Weizhu Yan,

Yanhui Zheng,

Xiao‐Tao Zeng

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2022, Номер 7(1)

Опубликована: Янв. 27, 2022

Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative agent of pandemic disease COVID-19, which so far without efficacious treatment. The discovery therapy reagents for treating COVID-19 are urgently needed, and structures potential drug-target proteins in viral life cycle particularly important. SARS-CoV-2, a member Orthocoronavirinae subfamily containing largest RNA genome, encodes 29 including nonstructural, structural accessory involved adsorption, entry uncoating, nucleic acid replication transcription, assembly release, etc. These individually act as partner machinery or forming complexes with host cellular factors to participate essential physiological activities. This review summarizes representative typically agents that target SARS-CoV-2 some critical pathogenesis, providing insights into mechanisms underlying infection, prevention Indeed, these studies open door COVID therapies, leading ways prevent treat especially, treatment caused by variants imperative.

Язык: Английский

Процитировано

251

SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance DOI Creative Commons
Xiantao Zhang,

Shijian Wu,

Bolin Wu

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2021, Номер 6(1)

Опубликована: Дек. 17, 2021

Процитировано

247

Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021 DOI Open Access

Lauren Jansen,

Bryan Tegomoh,

Kate Lange

и другие.

MMWR Morbidity and Mortality Weekly Report, Год журнала: 2021, Номер 70(5152), С. 1782 - 1784

Опубликована: Дек. 28, 2021

The B.1.1.529 (Omicron) variant of SARS-CoV-2 (the virus that causes COVID-19) was first detected in specimens collected on November 11, 2021, Botswana and 14 South Africa;* the confirmed case Omicron United States identified California December 1, 2021 (1). On 29, Nebraska Department Health Human Services notified six probable cases† COVID-19 one household, including a man aged 48 years index patient) who had recently returned from Nigeria. Given patient's travel history, infection suspected. Specimens all persons household tested positive for by reverse transcription-polymerase chain reaction (RT-PCR) testing following day genomic sequencing Public Laboratory an identical genotype each specimen (Figure). Phylogenetic analysis conducted to determine if this cluster represented independent introduction into States, detailed epidemiologic investigation conducted. This activity reviewed CDC consistent with applicable federal law policy.§.

Язык: Английский

Процитировано

183

Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study DOI Creative Commons
Hui‐Ling Yen,

Thomas H. C. Sit,

Christopher J. Brackman

и другие.

The Lancet, Год журнала: 2022, Номер 399(10329), С. 1070 - 1078

Опубликована: Март 1, 2022

Язык: Английский

Процитировано

180